Matsuoka M, Yoshida Y, Hayakawa K, Fukuchi S, Sugano K
Department of Gastroenterology, Mishuku Hospital, 5-33-12 Kamimeguro, Meguro-ku, Tokyo, Japan 153.
Gut. 1999 Oct;45(4):503-7. doi: 10.1136/gut.45.4.503.
It was recently reported that A to G transition mutations at positions 2143 and 2144 in the 23S rRNA gene are associated with clarithromycin resistance in Helicobacter pylori.
To study the incidence and mechanism of development of clarithromycin resistance by analysing these mutations.
Eighty two H pylori positive patients who had an endoscopic examination and no history of treatment with macrolide antibiotics.
Clarithromycin resistance was screened for by polymerase chain reaction-restriction fragment length polymorphism of the 23S rRNA gene coupled with antibiotic susceptibility testing. In clinical isolates with mutations or resistance, mutations in individual colonies were analysed by direct sequencing.
Of the 79 amplicons (DNA fragments amplified by polymerase chain reaction), Alw26I and MboII digestion disclosed the mutation in four (5%) and one (1%) respectively. However, the Alw26I cleavage was incomplete in two of the four amplicons, as was the MboII cleavage. Individual colony analysis of the isolates with incomplete cleavage patterns showed the presence of both wild type and mutated strains in the 23S rRNA genes.
Both clarithromycin sensitive and resistant strains colonised in some patients with no history of exposure to macrolides. The results suggest that resistant strains may not be formed but selected by clarithromycin administration.
最近有报道称,23S rRNA基因中第2143和2144位的A到G转换突变与幽门螺杆菌对克拉霉素的耐药性有关。
通过分析这些突变来研究克拉霉素耐药性的发生率和产生机制。
82例幽门螺杆菌阳性患者,这些患者接受了内镜检查且无大环内酯类抗生素治疗史。
通过23S rRNA基因的聚合酶链反应-限制性片段长度多态性结合抗生素敏感性试验来筛选克拉霉素耐药性。对于有突变或耐药的临床分离株,通过直接测序分析单个菌落中的突变情况。
在79个扩增子(通过聚合酶链反应扩增的DNA片段)中,Alw26I和MboII酶切分别在4个(5%)和1个(1%)中检测到突变。然而,在4个扩增子中的2个中Alw26I酶切不完全,MboII酶切也是如此。对酶切模式不完全的分离株进行单个菌落分析,结果显示在23S rRNA基因中同时存在野生型和突变型菌株。
在一些无大环内酯类药物接触史的患者中,同时存在克拉霉素敏感和耐药菌株。结果表明,耐药菌株可能不是由克拉霉素给药形成的,而是被其选择出来的。